Completed PHASE1 INTERVENTIONAL NCT00252252

AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation

Crossover Trial of VPAP (Variable Positive Airway Pressure) Ventilation Versus AutoVPAP in Neuromuscular and Chest Wall Disease: Effects on Nocturnal Hypoventilation, Sleep Quality and Tolerance

Sponsor: ResMed

Conditions Chest Wall Disorder Neuromuscular Disease

Interventions AutoVPAP non-invasive ventilator VPAP non-invasive ventilator

Updated 6 times since 2017 Last updated: Jun 20, 2008 Started: Nov 30, 2005 Primary completion: Jun 30, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Chest Wall Disorder and Neuromuscular Disease and is currently completed. ResMed leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1
Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ResMed
Royal Brompton & Harefield NHS Foundation Trust

Data source: ResMed

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom